KARYOPHARM THERAPEUTICS
Live / Registered — Registered and renewed (as of 06 Feb 2025)
What this means for you
Registered since 20 Jan 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Jan 2025).
Record
- Serial number
- 86051678
- Registration number
- 4676226
- Mark type
- Design + words
- Filed
- 29 Aug 2013
- Published for opposition
- 21 Jan 2014
- Registered
- 20 Jan 2015
- Next maintenance due
- 20 Jan 2025
- Attorney of record
- Nicole Kinsley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, drugs for the treatment of cancer, [inflammation] and [other ] diseases related to cell proliferation in humans [ and animals ]
Owner
- Karyopharm Therapeutics Inc., Newton, MA, US
- Karyopharm Therapeutics Inc., Newton, MA, US
- Karyopharm Therapeutics Inc., Natick, MA, US
Prosecution history
- 08 Dec 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 08 Dec 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 08 Aug 2025 — POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
- 07 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 25 Feb 2025 — REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
- 25 Feb 2025 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 06 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 06 Feb 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 06 Feb 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 Feb 2025 — POST REGISTRATION ACTION MAILED - SEC. 15
- 03 Feb 2025 — SEC. 15 ACKNOWLEDGEMENT - E-MAILED
- 03 Feb 2025 — REGISTERED - SEC. 15 ACKNOWLEDGED
- 03 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Jan 2025 — TEAS SECTION 8 & 9 RECEIVED